Purpose/Objectives: To identify previously unstudied factors predicting re-excision following breast-conserving surgery (BCS) and to assess the feasibility of obtaining data about breast density for predictive modeling. Design: Retrospective secondary data analysis. Setting: Data were obtained from...

Problem Identification: Women taking aromatase inhibitors (AIs) as part of the management of hormone receptor–positive breast cancer experience more symptoms of sexual dysfunction, including vaginal atrophy, as opposed to postmenopausal women and women treated with tamoxifen (Nolvadex®). Vaginal...

Problem Identification: Aromatase inhibitors (AIs) and the selective estrogen receptor modulator tamoxifen (Nolvadex®) are essential to extended survival for women with postmenopausal breast cancer. However, they can result in painful arthralgia. Literature Search: Databases searched for eligible...

Purpose/Objectives: Adjuvant endocrine therapy (AET) has been shown to improve survival in hormone receptor–positive breast cancer survivors, but as many as half do not complete recommended treatment. Management of medication-related side effects and engagement with providers are two potentially...